BioSpace News Archive

Drug Development

Clinical Catch-Up: Moderna, BioNTech, Eli Lilly & More Tout Positive Data

It was an extraordinarily busy week for clinical trial news and updates due to several prominent international conferences. Here’s a look at some of the highlights.

June 10, 2022
·
5 min read
·
Mark Terry
Policy

Genmab Seeks $405M from Janssen in Arbitration Over Royalty Payments

Genmab A/S is seeking a new arbitration ruling against Janssen seeking $405 million-plus interest in accrued milestone payments for Darzalex Faspro.

June 10, 2022
·
2 min read
·
Alex Keown
Drug Development

Roche, ADC and Caribou Get the Blood Pumping at EHA

The European Hematology Association’s 2022 Hybrid Congress is in full swing in Vienna, Austria and will feature the newest and most promising developments in blood cancer research.

June 10, 2022
·
5 min read
·
Tristan Manalac
Business

AbbVie Touts New Data for Rare Blood Cancer & Leukemia Treatments

AbbVie announced Friday that its investigational drug navitoclax, when used together with ruxolitinib, eases symptoms in myelofibrosis patients who had not yet been treated with a JAK inhibitor.

June 10, 2022
·
2 min read
·
Tristan Manalac
Career Advice

Show Me the Money: US Life Sciences Salaries, By Region

Location is everything when it comes to compensation in the life sciences. We’ve compiled data from BioSpace’s 2023 Life Sciences Salary Report to help you choose the best place to live and work.

June 10, 2022
·
4 min read
·
Franklin Carpenter
Policy

US Orders 500K Doses of Bavarian Nordic Monkeypox Vaccine

Bavarian Nordic announced the U.S. Biomedical Advanced Research and Development Authority has ordered an additional 500,000 doses of its monkeypox vaccine, Jynneos.

June 10, 2022
·
2 min read
·
Hayley Shasteen
FDA

US House Votes to Give FDA More Power Over Accelerated Approvals

The House of Representatives voted on a bill that would give the U.S. Food and Drug Administration more power to ensure biopharma companies run large follow-up trials to confirm accelerated approvals.

June 10, 2022
·
3 min read
·
Mark Terry
Drug Development

Cogent Soars on Positive Mid-Stage Data in Rare Blood Disorder

Cogent Biosciences shared its Phase II APEX clinical trial on bezuclastinib for patients with AdvSM and showed promise in treating the rare blood disorder.

June 10, 2022
·
2 min read
·
Vanessa Doctor, RN
New CRISPR-Based Map Opens Door to New Genetic Testing, Therapeutic Possibilities

Researchers from all around the world have been working on mapping human genes to their functions. Now, for the first time, that mapping has been completed.

June 10, 2022
·
3 min read
·
Hannah Chudleigh
Drug Development

bluebird bio Soars as FDA Adcom Recommends Second Gene Therapy

For the second straight day, the FDA’s Cell, Tissue and Gene Therapies Advisory Committee voted unanimously to approve a bluebird lentiviral vector (LVV) gene therapy.

June 10, 2022
·
4 min read
·
Mark Terry